EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Technical considerations for the implementation of the multi-attribute-method by mass spectrometry in a quality control laboratory

Thomas Pohl, Annick Gervais, Eef H C Dirksen, Valerio D'Alessio, Karoline Bechtold-Peters, Will Burkitt, Li Cao, Simone Greven, Andrew Lennard, Xue Li, Christopher Lössner, Ben Niu und 6 weitere

European Journal of Pharmaceutics and Biopharmaceutics · 2023-07 · 188 · 231-242

DOI: 10.1016/j.ejpb.2023.04.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2023-07. Verfasst von Thomas Pohl und 17 weiteren Autor:innen. Beteiligte Einrichtung: Biologics Analytical Development, Novartis Pharma AG, Klybeckstrasse 141, CH-4057 Basel, Switzerland. Electronic address: thomas.pohl@novartis.com. Hauptthemen laut MEDLINE: Laboratories, Drug Industry. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LaboratoriesDrug IndustryMass SpectrometryChromatography, LiquidQuality Control

Stichwörter der Autor:innen

Critical quality attributesLiquid chromatography mass spectrometryMulti-attribute methodNew peak detectionQuality control

Autor:innen und Institutionen

  • Biologics Analytical Development, Novartis Pharma AG, Klybeckstrasse 141, CH-4057 Basel, Switzerland. Electronic address: thomas.pohl@novartis.com.
  • Analytical Development Sciences for Biologicals, UCB, Chemin du Foriest, 1420 Braine L'Alleud, Belgium.
  • Analytical Development and Quality Control, Byondis, Microweg 22, 6545 CM, Nijmegen, the Netherlands.
  • Analytical Development Biotech, Merck Serono S.p.A., Via Luigi Einaudi, 11, 00012 Guidonia Montecelio Rome, Italy.
  • Biologics Drug Product Development, Novartis Pharma AG, Klybeckstrasse 141, CH-4057 Basel, Switzerland.
  • Biological Characterisation Product Development Sciences, UCB, 216 Bath Road, Slough SL1 3WE, UK.

Zitieren

APA

Pohl, T., Gervais, A., Dirksen, E. H. C., D'Alessio, V., Bechtold-Peters, K., Burkitt, W., Cao, L., Greven, S., Lennard, A., Li, X., Lössner, C., Niu, B., Reusch, D., O'Riordan, T., Shearer, J. W., Spencer, D., Xu, W., & Yi, L. (2023). Technical considerations for the implementation of the multi-attribute-method by mass spectrometry in a quality control laboratory. European Journal of Pharmaceutics and Biopharmaceutics, 188, 231-242. https://doi.org/10.1016/j.ejpb.2023.04.024

Vancouver

Pohl T, Gervais A, Dirksen EHC, D'Alessio V, Bechtold-Peters K, Burkitt W, et al. Technical considerations for the implementation of the multi-attribute-method by mass spectrometry in a quality control laboratory. European Journal of Pharmaceutics and Biopharmaceutics. 2023;188:231-242. doi:10.1016/j.ejpb.2023.04.024

BibTeX
@article{Pohl2023,
  author = {Pohl, Thomas and Gervais, Annick and Dirksen, Eef H C and D'Alessio, Valerio and Bechtold-Peters, Karoline and Burkitt, Will and Cao, Li and Greven, Simone and Lennard, Andrew and Li, Xue and Lössner, Christopher and Niu, Ben and Reusch, Dietmar and O'Riordan, Tomás and Shearer, Justin W and Spencer, David and Xu, Wei and Yi, Linda},
  title = {Technical considerations for the implementation of the multi-attribute-method by mass spectrometry in a quality control laboratory},
  journal = {European Journal of Pharmaceutics and Biopharmaceutics},
  year = {2023},
  volume = {188},
  pages = {231--242},
  doi = {10.1016/j.ejpb.2023.04.024}
}
Kostenlos starten →